TENAX THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
TENAX THERAPEUTICS, INC. (TENX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $31.33 thousand as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2022-03-29
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $31.33K.
- 2021-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $411.00.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.42K.
- 2019-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11.15K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2021-12-31 | $31.33K 10-K · filed 2022-03-29 |
| 2021-03-31 | $411.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.42K 10-K/A · filed 2021-04-16 |
| 2019-12-31 | $11.15K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |